Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 5,909 | 2,384 | 2,925 | 4,739 | 692 |
| Cost of Goods | 1,489 | 7,979 | 1,003 | 975 | 669 |
| Gross Profit | 1,015 | 162 | 995 | 1,221 | 24 |
| Operating Expenses | 3,601 | 5,763 | 2,041 | 3,301 | 2,728 |
| Operating Income | 1,308 | -10,379 | -116 | 1,438 | -2,036 |
| Interest Expense | 75 | 75 | 75 | 75 | 76 |
| Other Income | -2,996 | 8,497 | -723 | -2,321 | 167 |
| Pre-tax Income | -1,763 | -1,957 | -915 | -958 | -1,945 |
| Income Tax | 5 | -191 | 0 | 0 | -39 |
| Net Income Continuous | -1,496 | -1,801 | -1,001 | -850 | 850 |
| Net Income Discontinuous | 0 | -1,998,000 | 0 | 0 | 0 |
| Net Income | $-1,496 | $-1,801 | $-1,001 | $-850 | $850 |
| EPS Basic Total Ops | -8.80 | -11.20 | -5.60 | -6.40 | -13.60 |
| EPS Basic Continuous Ops | -8.90 | -11.12 | -6.34 | -5.51 | 6.08 |
| EPS Basic Discontinuous Ops | N/A | -12,333.33 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -8.80 | -11.20 | -6.40 | -5.60 | -14.40 |
| EPS Diluted Continuous Ops | -8.90 | -10.72 | -6.12 | -5.31 | 6.50 |
| EPS Diluted Discontinuous Ops | N/A | -11,892.86 | N/A | N/A | N/A |
| EBITDA(a) | $1,308 | $-10,379 | $-116 | $1,438 | $-2,036 |